Melatonin Improves Cognitive Deficits via Restoration of Cholinergic Dysfunction in a Mouse Model of Scopolamine-Induced Amnesia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chen, Bai Hui | - |
dc.contributor.author | Park, Joon Ha | - |
dc.contributor.author | Kim, Dae Won | - |
dc.contributor.author | Park, Jinseu | - |
dc.contributor.author | Choi, Soo Young | - |
dc.contributor.author | Kim, In Hye | - |
dc.contributor.author | Cho, Jeong Hwi | - |
dc.contributor.author | Lee, Tae-Kyeong | - |
dc.contributor.author | Lee, Jae Chul | - |
dc.contributor.author | Lee, Choong-Hyun | - |
dc.contributor.author | Hwang, In Koo | - |
dc.contributor.author | Kim, Young-Myeong | - |
dc.contributor.author | Yan, Bing Chun | - |
dc.contributor.author | Karig, Il Jun | - |
dc.contributor.author | Shin, Bich Na | - |
dc.contributor.author | Lee, Yun Lyul | - |
dc.contributor.author | Shin, Myoung Cheol | - |
dc.contributor.author | Cho, Jun Hwi | - |
dc.contributor.author | Lee, Young Joo | - |
dc.contributor.author | Jeon, Yong Hwan | - |
dc.contributor.author | Won, Moo-Ho | - |
dc.contributor.author | Ahn, Ji Hyeon | - |
dc.date.accessioned | 2021-08-11T11:44:10Z | - |
dc.date.available | 2021-08-11T11:44:10Z | - |
dc.date.issued | 2018-08 | - |
dc.identifier.issn | 1948-7193 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/5766 | - |
dc.description.abstract | Melatonin is known to improve cognitive deficits, and its functions have been studied in various disease models, including Alzheimer's disease. In this study, we investigated effects of melatonin on cognition and the cholinergic system of the septum and hippocampus in a mouse model of scopolamine-induced amnesia. Scopolamine (1 mg/kg) and melatonin (10 mg/kg) were administered intraperitoneally to mice for 2 and 4 weeks. The Morris water maze and passive avoidance tests revealed that both treatments of scopolamine significantly impaired spatial learning and memory; however, 2- and 4-week melatonin treatments significantly improved spatial learning and memory. In addition, scopolamine treatments significantly decreased protein levels and immunoreactivities of choline acetyltransferase (ChAT), high-affinity choline transporter (CHT), vesicular acetylcholine transporter (VAChT), and muscarinic acetylcholine receptor M1 (M1R) in the septum and hippocampus. However, the treatments with melatonin resulted in increased ChAT-, CHT-, VAChT-, and M1R-immunoreactivities and their protein levels in the septum and hippocampus. Our results demonstrate that melatonin treatment is effective in improving the cognitive deficits via restoration of the cholinergic system in the septum and hippocampus of a mouse model of scopolamine-induced amnesia. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | American Chemical Society | - |
dc.title | Melatonin Improves Cognitive Deficits via Restoration of Cholinergic Dysfunction in a Mouse Model of Scopolamine-Induced Amnesia | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1021/acschemneuro.7b00278 | - |
dc.identifier.wosid | 000442184300016 | - |
dc.identifier.bibliographicCitation | ACS Chemical Neuroscience, v.9, no.8, pp 2016 - 2024 | - |
dc.citation.title | ACS Chemical Neuroscience | - |
dc.citation.volume | 9 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 2016 | - |
dc.citation.endPage | 2024 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.subject.keywordPlus | ALZHEIMERS-DISEASE | - |
dc.subject.keywordPlus | DENTATE GYRUS | - |
dc.subject.keywordPlus | MEMORY IMPAIRMENT | - |
dc.subject.keywordPlus | BASAL FOREBRAIN | - |
dc.subject.keywordPlus | DOWN-SYNDROME | - |
dc.subject.keywordPlus | MICE | - |
dc.subject.keywordPlus | RATS | - |
dc.subject.keywordPlus | SYSTEM | - |
dc.subject.keywordPlus | NEUROGENESIS | - |
dc.subject.keywordPlus | HIPPOCAMPUS | - |
dc.subject.keywordAuthor | Cholinergic degeneration | - |
dc.subject.keywordAuthor | cognitive deficits | - |
dc.subject.keywordAuthor | hippocampus | - |
dc.subject.keywordAuthor | medial septum | - |
dc.subject.keywordAuthor | melatonin | - |
dc.subject.keywordAuthor | neurohormone | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.